|

Parkinson's Disease Clinical Trials in Miami, FL

23 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 3<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease—<1 mi
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseasePhase 2<1 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 2<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
Parkinson's Foundation Surveys—<1 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—<1 mi
Use of CereGate Therapy for Freezing of Gait in PDN/A<1 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 4<1 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—<1 mi
Low Versus High Load Training and Parkinson's DiseaseN/A6 mi
Periodization and Parkinson's DiseaseN/A6 mi
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's DiseasePhase 29 mi
A Study of Buntanetap in Participants With PDPhase 2/314 mi
Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care PartnersN/A21 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 242 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 242 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 342 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—42 mi
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)Phase 242 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—42 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 342 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/342 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.